In 2019, the National Multiple Sclerosis Society published a series of findings with updated prevalence of the disease. Current estimates place the number of people diagnosed with Multiple Sclerosis (MS) at one million people in the US; double previously reported figures. It is a costly and chronic disease without an exact known cause or biomarker,…

February is low-vision month, and at PurpleLab we are focusing on Age-Related Macular Degeneration (AMD), one of the diseases responsible for this condition.  According to the Centers for Disease Control’s (CDC) Vision and Eye Health Surveillance System (VEHSS) about twenty million Americans aged forty and older are living with AMD; 1.5 million of which are…

Commercial launch strategies require research, insight gathering and decision-making for years in advance of FDA submission. These processes involve complex requirements and often involve timelines and project plans that are mapped out across functional teams and their agency partners. As teams move quickly into “launch mode”, there are many potential shifting priorities requiring contingency plans…

Compared to those in other fields, in many ways, life sciences marketers need much more precision when it comes to audience segmentation and targeting. The pharmaceutical brands that they are advertising often have very precise indications, which means the drug’s value and benefits are only relevant to a niche audience. For example, imagine that your…

Today’s Life Science organizations expend significant resources to capture and hold the attention of patients and healthcare providers (HCPs) in the digital ecosystem. In 2022, the average U.S. consumer spent more than eight hours a day consuming digital content. Physicians are among the busiest employees in the US, as well as consumers— some survey findings…

While only half as many are diagnosed, researchers estimate that hypothyroidism affects as much as 10% of the general population. Also known as “underactive thyroid,” this condition is characterized by a thyroid gland that doesn’t produce enough thyroid hormone (TH).

As organizations in life sciences continue to grow and evolve, the strategies they use to reach healthcare providers (HCPs) and patients are following suit. Doctors and patients are inundated with more and more information across digital and traditional channels about relevant diseases, gold-standard treatments, and their various benefits.

To create a market assessment, more and more brand strategists are moving towards the use of RWD and RWE. In this blog, we walk through a hypothetical example – sizing the market for Hemophilia A – doing just that.  Creating a market assessment is a critical step in commercializing a new drug. This is because…

Developing, testing and getting approval for a new drug is a tough feat – but only half the battle. Now that your new drug is ready to be commercialized, you have to get it to the right patients, which starts with finding the right physicians. Here’s how this process works – and how to use…